Skip to content
healthcare.dev

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen

NDC 0002-8233, Insulin lispro, injection, suspension, from Eli Lilly and Company.

Product NDC
0002-8233
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA021017
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8233 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN LISPRO100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [Chemical/Ingredient]

Package NDCNDC-11Package
0002-8233-05000028233055 SYRINGE in 1 CARTON (0002-8233-05) / 3 mL in 1 SYRINGE (0002-8233-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e49f701d-c19f-4cb2-b63f-01a917b33abc
  • NADAC price for package 00002823305

    GET /v1/drugs/nadac/00002823305

Use it

Look up 0002-8233 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8233 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-8233. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.